Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-01 23:06:07 - browse：579

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： India sets sights on home

WSS

India sets sights on home

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Readout Newsletter: What happened with Sarepta's Duchenne data

Why some people catch Covid but never get sick

Physician subsidies by hospitals soar in wake of No Surprises Act

The kidney, in all its complexity, is captured in a new atlas

knowledge

Wikipedia

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Medical leaders decry Supreme Court decision on affirmative action

FDA has safety concerns on CRISPR

Walensky prepares to leave CDC — and Congress — behind

Medical experts are missing from AI regulatory conversations

23andMe had bad news about my health. I wish a person had delivered it

New warning issued for rebooking air travel after delays, cancellations

Cancer drug shortages should be causing more outrage

Resistance to cancer drugs: A new genetic explanation

hotspot

Readout Newsletter: XBI biotech index, Akero Therapeutics

Hospitals warn Medicare's drug payment fix is ‘unlawful’

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

WHO may add ‘noma' to its list of neglected tropical diseases

Medtronic CEO on promising devices for diabetes, hypertension

FDA has safety concerns on CRISPR

leisure time

hotspot

knowledge

hotspot